東北大学加齢医学研究所 臨床腫瘍学分野 東北大学 腫瘍内科

研究関係

HOME < 研究業績 < 英文論文 2011年度

英文論文 2011年度

  1. Sakamoto, Y.,Kato, S.,Takahashi , M.,Okada, Y.,Yasuda, K.,Watabe, G.,Imai, H.,Sato, A.,Ishioka, C. Contribution of autphagic cell death to p53-dependent cell death in human glioblastoma cell line SF126. Cancer Sci Apr;102(4): 799-807 (2011)
  2. Kais, Z.,Chiba.N,Ishioka, C.,Parrvin, J. Functional differences among BRCA1 missense mutations in the control of centrosome duplication. Oncogene (2011)
  3. Sato, A.,Kudo, C.,Yamakoshi, H.,Uehara, Y.,Ohrui, H.,Ishioka, C.,Iwabuchi, Y.,Shibata, H. Curcumin analog GO-Y030 is a novel inhabitor of IKKβ that suppresses NF-kB signaling and induces apotosis. Cancer Sci. 105(2): 1045-51 (2011)
  4. Kudo, C.,Yamakoshi, H.,Sato, A.,Nanjyo, H.,Ohrui, H.,Ishioka, C.,Iwabuchi, Y.,Shibata, H. Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo. BMC Pharmacol. 11: 4 (2011)
  5. Takahashi, M., Koi, M., Balaguer, F., Boland, C.R., Goel, A. MSH3 Mediates Sensitization of Colorectal Cancer Cells to Cisplatin, Oxaliplatin, and a Poly(ADP-ribose) Polymerase Inhibitor. J Biol Chem. Apr 8;286(14):12157-65. (2011)
  6. Kudo, C.,Yamakoshi, H.,Sato, A.,Ohori, H.,Ishioka, C.,Iwabuchi, Y.,Shibata, H. Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma. Anticancer Res (11):37: 19-26 (2011)
  7. Wei L,Lan L,Yasui A,Tanaka K,Saijo M,Matsuzawa A,Kashiwagi R,Maseki E,Hu Y,Parvin JD,Ishioka C,N., C. BRCA1 contributes to transcription-coupled repair of DNA damage through polyubiquitination and degradation of Cockayne syndrome B protein. Cancer Sci. 102(10): 1840-7. (2011)
  8. Yoshida, K.,Nagai, T.,Ohmine, K.,Uesawa, M.,Sripayap, P.,Ishida, Y.,Ozawa, K. Vincristine potentiates the anti-proliferative effect of an aurora kinase inhibitor, VE-465, in myeloid leukemia cells. Biochem Pharmacol 82: 1884-90 (2011)

ページの先頭へ戻る

© 2006 Department of Medical Oncology, Tohoku University Hospital All rights reserved.